Rosalind Advisors, Inc.

CIK

1622627

Location

TORONTO, A6

Portfolio Value

Small $244,512,536

Diversification

Diversified

Filing Date

Global Rank

#3,805 / 8,586 ▲ 41

Top Industry

Biotechnology 68.2%

3Y Alpha vs SPY

-11.8%

Period ended 3 months ago

Filed May 14, 2026 · 33d

10 quarters · since Dec 2023

Clone Performance

Feb 2024–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio

+22.7%

SPY

+55.8%

Annualised alpha

-11.8%

Max drawdown

−25.0%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

32 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

12.5%

−0.7 pts

Top 5

41.6%

+0.1 pts

Top 10

67.1%

−1.1 pts

HHI

577

Diversified−44

Portfolio Trend

10 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$244,512,536	32

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

7 positions

Ticker	Company	Δ Shares	Shares	Value
XERS	Xeris Biopharma Holdings, Inc.	+1,120,000	3,231,700	$18,743,860
XFOR	X4 Pharmaceuticals, Inc	+608,846	3,214,766	$13,276,983
VSTM	Verastem, Inc.	+350,000	2,138,475	$11,333,917
EYPT	EyePoint, Inc.	+346,737	1,036,737	$13,363,539
FENC	Fennec Pharmaceuticals Inc.	+294,693	2,908,201	$17,885,436
BFRI	Biofrontera Inc.	+23,198	1,163,962	$941,645
MYO	Myomo, Inc.	+7,500	3,847,272	$2,600,755
No positions match the current search.

Trimmed

Positions the filer reduced

8 positions

Ticker	Company	Δ Shares	Shares	Value
OKUR	OnKure Therapeutics, Inc.	−286,725	443,763	$1,837,178
PROF	Profound Medical Corp.	−240,837	828,118	$5,366,204
TLPH	Talphera, Inc.	−225,357	3,353,916	$2,515,437
CGON	CG Oncology, Inc.	−200,000	100,000	$6,768,000
SVRA	Savara Inc	−200,000	3,203,721	$17,492,316
VRDN	Viridian Therapeutics, Inc.DE	−199,599	250,401	$4,897,843
HELP	Cybin Inc.	−125,726	1,531,814	$7,352,707
PYPD	PolyPid Ltd.	−98,630	597,926	$2,618,915
No positions match the current search.

New Positions

Positions the filer opened this quarter

11 positions

Ticker	Company	Shares	Value
PCVX	Vaxcyte, Inc.	290,000	$16,851,900
VOR	Vor Biopharma Inc.	700,000	$12,488,000
CLDX	Celldex Therapeutics, Inc.	330,000	$10,467,600
BCRX	Biocryst Pharmaceuticals Inc	923,057	$8,787,502
AVIR	Atea Pharmaceuticals, Inc.	1,171,855	$6,304,579
OVID	Ovid Therapeutics Inc.	1,107,994	$2,459,746
DFTX	Definium Therapeutics, Inc.	125,000	$2,362,500
LPCN	Lipocine Inc.	221,616	$1,770,711
AVTX	Avalo Therapeutics, Inc.	75,000	$1,119,750
ANNX	Annexon, Inc.	200,000	$1,108,000
AQST	Aquestive Therapeutics, Inc.	250,000	$1,037,500
No positions match the current search.

Sold Out

Positions the filer fully exited

7 positions

Ticker	Company	Shares	Value
REPL	Replimune Group, Inc.	1,410,497	$13,710,030
CYTK	Cytokinetics Inc	195,045	$12,393,159
OCUL	Ocular Therapeutix, Inc	400,000	$4,856,000
AVBP	ArriVent BioPharma, Inc.	215,871	$4,343,324
TRVI	Trevi Therapeutics, Inc.	100,000	$1,252,000
GUTS	Fractyl Health, Inc.	385,731	$848,608
ATYR	aTYR PHARMA INC	1,039,080	$813,599
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

32 positions · $244,512,536 total · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
DCTH	Delcath Systems, Inc. Healthcare	Held	3,300,389	0	$30,627,609	−8.1%	12.53%
XERS	Xeris Biopharma Holdings, Inc. Healthcare	Added	3,231,700	+1,120,000	$18,743,860	+13.1%	7.67%
FENC	Fennec Pharmaceuticals Inc. Healthcare	Added	2,908,201	+294,693	$17,885,436	−11.1%	7.31%
SVRA	Savara Inc Healthcare	Reduced	3,203,721	-200,000	$17,492,316	−14.8%	7.15%
PCVX	Vaxcyte, Inc. Healthcare	NEW	290,000	NEW	$16,851,900	NEW	6.89%
EYPT	EyePoint, Inc. Healthcare	Added	1,036,737	+346,737	$13,363,539	+6.0%	5.47%
XFOR	X4 Pharmaceuticals, Inc Healthcare	Added	3,214,766	+608,846	$13,276,983	+27.4%	5.43%
VOR	Vor Biopharma Inc. Healthcare	NEW	700,000	NEW	$12,488,000	NEW	5.11%
MDWD	MediWound Ltd. Healthcare	Held	749,054	0	$12,067,259	−12.7%	4.94%
VSTM	Verastem, Inc. Healthcare	Added	2,138,475	+350,000	$11,333,917	−17.9%	4.64%
CLDX	Celldex Therapeutics, Inc. Healthcare	NEW	330,000	NEW	$10,467,600	NEW	4.28%
BCRX	Biocryst Pharmaceuticals Inc Healthcare	NEW	923,057	NEW	$8,787,502	NEW	3.59%
HELP	Cybin Inc. Healthcare	Reduced	1,531,814	-125,726	$7,352,707	−45.8%	3.01%
CGON	CG Oncology, Inc. Healthcare	Reduced	100,000	-200,000	$6,768,000	−45.7%	2.77%
NSPR	InspireMD, Inc. Healthcare	Held	3,905,743	0	$6,366,361	−8.4%	2.60%
AVIR	Atea Pharmaceuticals, Inc. Healthcare	NEW	1,171,855	NEW	$6,304,579	NEW	2.58%
PROF	Profound Medical Corp. Healthcare	Reduced	828,118	-240,837	$5,366,204	−36.2%	2.19%
VRDN	Viridian Therapeutics, Inc.DE Healthcare	Reduced	250,401	-199,599	$4,897,843	−65.0%	2.00%
PYPD	PolyPid Ltd. Healthcare	Reduced	597,926	-5,582,073	$2,618,915	−90.2%	1.07%
MYO	Myomo, Inc. Healthcare	Added	3,847,272	+7,500	$2,600,755	−25.6%	1.06%
TLPH	Talphera, Inc. Healthcare	Reduced	3,353,916	-225,357	$2,515,437	−38.4%	1.03%
OVID	Ovid Therapeutics Inc. Healthcare	NEW	1,107,994	NEW	$2,459,746	NEW	1.01%
DFTX	Definium Therapeutics, Inc. Healthcare	NEW	125,000	NEW	$2,362,500	NEW	0.97%
NRXS	Neuraxis, INC Healthcare	Held	286,138	0	$2,117,421	+63.0%	0.87%
OKUR	OnKure Therapeutics, Inc. Healthcare	Reduced	443,763	-286,725	$1,837,178	−13.3%	0.75%
LPCN	Lipocine Inc. Healthcare	NEW	221,616	NEW	$1,770,711	NEW	0.72%
AVTX	Avalo Therapeutics, Inc. Healthcare	NEW	75,000	NEW	$1,119,750	NEW	0.46%
ANNX	Annexon, Inc. Healthcare	NEW	200,000	NEW	$1,108,000	NEW	0.45%
AQST	Aquestive Therapeutics, Inc. Healthcare	NEW	250,000	NEW	$1,037,500	NEW	0.42%
BFRI	Biofrontera Inc. Healthcare	Added	1,163,962	+23,198	$941,645	+44.8%	0.39%
KURA	Kura Oncology, Inc. Healthcare	Held	100,000	0	$813,000	−21.8%	0.33%
RGNT	Regentis Biomaterials Ltd. Healthcare	Held	251,510	0	$768,363	−54.7%	0.31%